Page 6 - Oral Solution News Today

Investors in India rode the sleigh of a dovish U.S. Federal Reserve, which hinted at three rate cuts in 2024, leading to a global surge in equities. On December 15, the Indian market joined the global rally, marking another session of bullish momentum.

On Thursday, 2064 stocks advanced, 1702 declined and 126 remained unchanged, with an advance decline ratio of 1.21 on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader markets.

InvaGen Pharmaceuticals Inc., affiliated to Cipla Ltd., is recalling one lot of Vigabatrin for Oral Solution, USP, citing leakage issues, according to the U.S Food and Drug Administration or FDA.

Stocks to watch out for today: Tata Motors, HCL Tech, Max Healthcare, Cipla, Fedbank Financial Services, SpiceJet, Sudev Industries, Torrent Power and more

Jaykay Enterprises has completed the execution of MoU with Philips Machine Tools India to synergistically expand each others businesses on Pan India and in global markets.

Tata Motors to Increase Prices of Commercial Vehicles - Clayton County Register

Cipla Limited today announced that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc. is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP 500mg, to the consumer level.

Cipla’s subsidiary InvaGen Pharmaceuticals is recalling 1 lot of Vigabatrin for Oral Solution 500mg due to seal integrity issues that result in the powder leaking from the pouch.

The product is used for the treatment of refractory complex partial seizures as adjunctive therapy in patients 2 years of age and older

Cipla, in a regulatory filing, said InvaGen Pharmaceuticals is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP (500 mg), at the consumer level due to seal integrity issues, allowing for powder leakage from the pouch